Several studies have demonstrated that MCL-1 and Bcl-2 are overexpressed frequently in AML cell lines, with high expression levels being associated with poor prognoses and resistance to chemotherapy (Delia et al., 1992; Fowler-Shorten et al., 2024). Here, MCL1 is linked to acute myeloid leukemia.